Physiomics Plc Stock Forecast for 2023 - 2025 - 2030
Updated on 05/05/2024
Physiomics Plc Stock Forecast and Price Target
The average target price for Physiomics Plc's stock set by renowned analysts in recent months is £0.01, representing a potential downside of approximately 0% from its last closing price if met by 2025. This estimation is based on a high estimate of £0.01 and a low estimate of £0.00. Even if not interested in PYC stock, you may want to be aware of its competitors.
0.00% Upside
Physiomics Plc Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Physiomics Plc's Price has increased by 100.00%, going from £-0.00 to £0.00. In the next year, analysts are expecting an increase in Fair Value, predicting it will reach £0.01 – an increase of 100.00%. The Physiomics Plc forecast is for Fair Value to reach £0.02 or grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| GWPH Stock Forecast | GW Pharmaceuticals | - |
6
|
$219.00 | Buy/Sell | $188.33 | 5.14% |
| ABCM Stock Forecast | Abcam | - |
18
|
$23.99 | Buy/Sell | $19.25 | -67.15% |
| GNS Stock Forecast | Genus | Buy |
18
|
£18.68 | Buy/Sell | £33.09 | 47.22% |
| AUTL Stock Forecast | Autolus Therapeutics | Buy |
6
|
$4.19 | Buy/Sell | $9.23 | 162.53% |
| BCYC Stock Forecast | Bicycle Therapeutics | Outperform |
7
|
$24.58 | Buy/Sell | $44.47 | 74.94% |
Physiomics Plc Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Physiomics Plc's Revenue has fallen from £840.00k to £610.00k – a 27.38% decrease. In the next year, analysts are expecting an increase in Revenue, predicting it will reach £698.90k – an increase of 14.57%. The Physiomics Plc forecast is for Revenue to reach £757.39k or grow by 24.16%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| SLN Stock Forecast | Silence Therapeutics | Outperform |
7
|
$21.99 | Buy/Sell | $42.75 | 127.38% |
| CMPS Stock Forecast | COMPASS Pathways | Buy |
3
|
$8.53 | Buy/Sell | $45.43 | 222.39% |
| MREO Stock Forecast | Mereo BioPharma Group | Buy |
5
|
$3.26 | Buy/Sell | $3.46 | 46.32% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ORTX Stock Forecast | Orchard Therapeutics | - |
7
|
$16.70 | Buy/Sell | $16.00 | -100.00% |
| NIOX Stock Forecast | NIOX Group Plc | Buy |
6
|
£0.70 | Buy/Sell | £0.76 | 10.00% |
| OXB Stock Forecast | Oxford Biomedica | Outperform |
10
|
£3.28 | Buy/Sell | £4.24 | 19.82% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ADAP Stock Forecast | Adaptimmune Therapeutics | Outperform |
7
|
$1.19 | Buy/Sell | $3.60 | 110.08% |
| BVXP Stock Forecast | Bioventix PLC |
18
|
£43.25 | Buy/Sell | £44.00 | 36.42% | |
| HZD Stock Forecast | Horizon Discovery Group | - |
3
|
£0.00 | Buy/Sell | £0.00 | 0.00% |
Physiomics Plc EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Physiomics Plc's EBITDA has grown, increasing from £-120.00k to £-560.00k – a growth of 366.67%. For the following year, the 0 analysts predict that Physiomics Plc's EBITDA will drop by 36.19%, reaching £-357.34k. In 2030, the professionals' prediction is that PYC's EBITDA will decrease by 28.45%, reaching £-400.69k.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ETX Stock Forecast | e-therapeutics |
9
|
£0.16 | Buy/Sell | £0.16 | -100.00% | |
| AGY Stock Forecast | Allergy Therapeutics | - |
12
|
£0.03 | Buy/Sell | £0.50 | -100.00% |
| SCLP Stock Forecast | Scancell Holdings | Buy |
4
|
£0.09 | Buy/Sell | £0.23 | 155.56% |
Physiomics Plc EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Physiomics Plc's EBIT has grown by 338.46%, from £-130.00k to £-570.00k. In the following year, the 1 analysts surveyed believe that Physiomics Plc's EBIT will decrease by 21.05%, reaching £-450.00k. According to professionals, by 2030, Physiomics Plc's EBIT will have decreased by 22.64%, falling down to £-440.95k.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BRNS Stock Forecast | Barinthus Biotherapeutics | Outperform |
2
|
$2.18 | Buy/Sell | $8.80 | 221.10% |
| REDX Stock Forecast | Redx Pharma Plc | - |
9
|
£0.17 | Buy/Sell | £1.25 | -100.00% |
| DDDD Stock Forecast | 4D pharma | - |
7
|
£0.36 | Buy/Sell | £0.00 | -100.00% |
Physiomics Plc EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Physiomics Plc's EPS has increased by 100.00%, going from £-0.00 to £0.00. In the next year, analysts are expecting an increase in EPS, predicting it will reach £0.00 – an increase of 100.00%. The Physiomics Plc forecast is for EPS to reach £0.00 or grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| NANO Stock Forecast | Nanoco Group |
8
|
£0.19 | Buy/Sell | £0.09 | 215.79% | |
| DNL Stock Forecast | Diurnal Group | - |
0
|
£0.27 | Buy/Sell | £0.69 | -100.00% |
| TLSA Stock Forecast | Tiziana Life Sciences Ltd | Buy |
2
|
$0.52 | Buy/Sell | $5.00 | 363.46% |
.jpg)